Wanbury Limited reports 11.6% growth in revenue for Q2 FY25, EBITDA surges 19.6%

Wanbury Limited, a leading pharmaceutical company with a global footprint in active pharmaceutical ingredients (APIs) and domestic branded formulations, has announced a stellar financial performance ... Read More